In what may prove to be a major step toward the promotion of nasal mist forms of influenza vaccine, the Food and Drug Administration (FDA) has approved FluMist (Influenza Virus Vaccine Live, Intranasal) to be converted from its frozen formulation to a liquid. This approval eliminates a roadblock experienced by those health care providers faced…
Are you a Member of NAHC?
Become a member or sign in and read full NAHC Report articles at your leisure. Membership is affordable even if you're a small business and it comes with a lot of other benefits.